enzalutamide
astellas,pfizer
['prostate', '5074', 'arches', 'pfizer']
see a post hoc analysis of the arches study assessing prevalence of ddr alterations &amp; associated baseline characteristics in pts w/ metastatic hormone-sensitive #prostatecancer receiving an androgen receptor inhibitor + adt or placebo + adt #asco22 5074 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ